Zobrazeno 1 - 10
of 9 510
pro vyhledávání: '"Michiels, S"'
Autor:
Mosele, M.F., Westphalen, C.B., Stenzinger, A., Barlesi, F., Bayle, A., Bièche, I., Bonastre, J., Castro, E., Dienstmann, R., Krämer, A., Czarnecka, A.M., Meric-Bernstam, F., Michiels, S., Miller, R., Normanno, N., Reis-Filho, J., Remon, J., Robson, M., Rouleau, E., Scarpa, A., Serrano, C., Mateo, J., André, F.
Publikováno v:
In Annals of Oncology July 2024 35(7):588-606
Autor:
Courtinard, C., Barbet, V., Schiappa, R., Pilleul, F., Michiels, S., Dabakuyo, S., Gourgou, S., Jaffre, A., Asselain, B., Bosquet, L., Dunton, K., Rosenlund, M., Liang, Z., Cathcart, J., Delaloge, S.
Publikováno v:
In ESMO Real World Data and Digital Oncology June 2024 4
Autor:
Ba, M.B. ∗, Giudici, F. †, Bellini, C. ∗, Auzac, G. ∗, Louvel, G. ∗, Bockel, S. ∗, Moukasse, Y. ∗, Chaffai, I. ∗, Berthelot, K. ∗, Vatonne, A. ∗, Conversano, A. ‡, Viansone, A. §, Larue, C. †, Deutsch, E. ∗, ¶, Michiels, S. †, Milewski, C. ∗, Rivera, S. ∗, ¶, ⁎
Publikováno v:
In Clinical Oncology September 2024 36(9):e333-e341
Publikováno v:
In ESMO Open March 2024 9(3)
Autor:
Sablin MP; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Gestraud P; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Jonas SF; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Lamy C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Lacroix-Triki M; Department of Pathology, Gustave Roussy, Villejuif, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Filleron T; Department of Biostatistics, Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France., Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Genomic Platform and Biobank, CNRS UMS3655-INSERM US23, AMMICA, Gustave Roussy, Villejuif, France., Tran-Dien A; Bioinformatics Platform, Gustave Roussy, Villejuif, France., Jézéquel P; Omics Data Science Unit, Institut de Cancérologie de l'Ouest (ICO), Angers-Nantes, France., Mauduit M; Precision Medicine Group, UNICANCER, Paris, France., Barros Monteiro J; R&D Unicancer, Paris, France., Jimenez M; Precision Medicine Group, UNICANCER, Paris, France., Michiels S; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Attignon V; Cancer Genomic Platform, Centre Léon Bérard, Lyon, France., Soubeyran I; Department of Biopathology, Institut Bergonié, Bordeaux, France., Driouch K; Department of Genetics, Institut Curie, Paris University, Paris, France., Servant N; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Bièche I; Department of Genetics, Institut Curie, Paris University, Paris, France. ivan.bieche@curie.fr.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Aug 02. Date of Electronic Publication: 2024 Aug 02.
Autor:
Favier, A. *, Boinon, D., Salviat, F., Mazouni, C., De Korvin, B., Tunon, C., Salomon, A.-V., Doutriaux-Dumoulin, I., Vaysse, C., Marchal, F., Boulanger, L., Chabbert-Buffet, N., Zilberman, S., Coutant, C., Espié, M., Cortet, M., Boussion, V., Cohen, M., Fermeaux, V., Mathelin, C., Michiels, S., Delaloge, S., Uzan, C., Charles, C.
Publikováno v:
In Gynécologie Obstétrique Fertilité & Sénologie February 2022 50(2):142-150
Publikováno v:
In Annals of Oncology October 2021 32(10):1236-1244
Autor:
Di Meglio A; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France. Electronic address: antonio.di-meglio@gustaveroussy.fr., Havas J; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France., Pagliuca M; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France; Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Franzoi MA; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France., Soldato D; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France., Chiodi CK; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France., Gillanders E; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France., Dubuisson F; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Camara-Clayette V; Biological Resource Center, AMMICa, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France., Pistilli B; Medical Oncology Department, INSERM U981, Gustave Roussy, Villejuif, France., Ribeiro J; Medical Oncology Department, INSERM U981, Gustave Roussy, Villejuif, France., Joly F; Centre Francois Baclesse, University UniCaen, Anticipe U1086 Inserm, Caen, France., Cottu PH; Institut Curie, Paris, France., Tredan O; Centre Léon Bérard, Lyon, France., Bertaut A; Centre Georges François Leclerc, Dijon, France., Ganz PA; University of California, Los Angeles, CA, United States., Bower J; University of California, Los Angeles, CA, United States., Partridge AH; Dana-Farber Cancer Institute, Boston, MA, United States., Martin AL; Unicancer, Paris, France., Everhard S; Unicancer, Paris, France., Boyault S; Centre Georges François Leclerc, Dijon, France., Brutin S; Biological Resource Center, AMMICa, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France., André F; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France., Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled « Ligue Contre le Cancer », France., Pradon C; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France; Biological Resource Center, AMMICa, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France., Vaz-Luis I; Cancer Survivorship Program, INSERM U981, Gustave Roussy, Villejuif, France; Interdisciplinary Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Aug 02. Date of Electronic Publication: 2024 Aug 02.
Autor:
Geurts VCM; Division of Tumor Biology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Balduzzi S; Department of Biometrics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Steenbruggen TG; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Internal Medicine, St Antonius Hospital, Nieuwegein, the Netherlands., Linn SC; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Siesling S; Department of Research and Development, the Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Health, Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., Badve SS; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute, Emory University, Atlanta, Georgia., DeMichele A; Department of Medicine, University of Pennsylvania, Philadelphia., Ignatiadis M; Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium., Leon-Ferre RA; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Goetz MP; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Wolff AC; Department of Medicine, Johns Hopkins University, Baltimore, Maryland., Klar N; Perlmutter Cancer Center, New York University, New York.; Grossman School of Medicine, New York University, New York., Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018, Inserm, Paris-Saclay University, labeled Ligue Contre le Cancer, Villejuif, France., Loi S; Division of Cancer Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Parkville, Australia., Adams S; Perlmutter Cancer Center, New York University, New York.; Grossman School of Medicine, New York University, New York., Horlings HM; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Salgado R; Department of Pathology, Ziekenhuis aan de Stroom (ZAS), Antwerp, Belgium.; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia., Kok M; Division of Tumor Biology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Aug 01; Vol. 10 (8), pp. 1077-1086.
Autor:
Michiels S; Department of Digestive Surgery, IRIS Hospitals South, Université Libre de Bruxelles, Brussels, Belgium., Engelholm JL; Department of Radiology, IRIS Hospitals South, Université Libre de Bruxelles, Brussels, Belgium.
Publikováno v:
Acta chirurgica Belgica [Acta Chir Belg] 2024 Aug; Vol. 124 (4), pp. 307-311. Date of Electronic Publication: 2023 Jul 10.